Skip to main content
. 2023 Aug 23;36:11590. doi: 10.3389/ti.2023.11590

TABLE 5.

Original diagnoses on the 37 cases, panelists’ responses, percentage agreement (%A) and percentage agreement levels (%AL).

Case # Original diagnoses Panelist responses (%A) (%AL)
TMA No TMA TMA No TMA 61–80 %AL in 31/37 cases (83.8%) 81–96 %AL in 20/37 cases (54.1%) 97–100 %AL in 4/37 cases (10.8%)
1 TMA (diffuse) 19 4 83 17 X X
2 TMA (focal) + AMR 22 1 96 4 X X
3 TMA (acute & chronic) 23 0 100 0 X X X
4 TMA (classical case) 22 1 96 4 X X
5 TMA (classical case) 22 1 96 4 X X
6 TMA (early) 11 12 48 52
7 TMA found on EM only 8 15 35 65 X
8 TMA found on EM only 4 19 17 83 X X
9 TMA (classical case) 22 1 96 4 X X
10 AMR + TMA 12 11 52 48
11 TMA (classical case) 19 4 83 17 X X
12 No TMA (suspicious for AMR) 7 16 30 70 X
13 No TMA (TCMR +C4d-neg AMR) 5 18 22 78 X
14 Subtle TMA + CNI tox 14 9 61 39
15 TMA (classical case) 20 3 87 13 X X
16 TMA (classical case) 17 6 74 26 X
17 TMA with rare thrombi 19 4 83 17 X X
18 TMA with small thrombi 5 18 22 78 X
19 No TMA (GN with deposits) 4 19 17 83 X X
20 TMA (acute and chronic) 22 1 96 4 X X
21 TMA (acute and chronic) 21 2 91 9 X X
22 TMA + Nephrosclerosis 18 5 78 22 X
23 No TMA (chronic AMR + TG + weak C4d+) 10 13 43 57
24 No TMA (chronic AMR + TG + weak C4d+) 6 17 26 74 X
25 TMA (classical case) 22 1 96 4 X X
26 TMA (classical case) 21 2 91 9 X
27 TMA + Hypertensive arteriopathy 21 2 91 9 X
28 TMA (classical case) 23 0 100 0 X X X
29 TCMR 5 18 22 79 X
30 TMA (focal) + AMR 12 11 52 48
31 TMA (classical case) 21 2 91 9 X X
32 No TMA 12 11 52 48
33 TMA (classical case) 23 0 100 0 X X X
34 No TMA (rec. MPGN) 14 19 42 58 X
35 No TMA (rec. IgA nephropathy) 2 21 9 91 X X
36 TMA (classical case) 23 0 100 0 X X X
37 TMA + AMR 21 2 91 9 X X